ARCT FY 2021 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+29.6% YoY

Gross Profit

$12M100.0% margin

Operating Income

-$203M-1641.3% margin

Net Income

-$204M-1648.0% margin

EPS (Diluted)

$-7.74

Cash Flow

Operating Cash Flow

-$135M

Free Cash Flow

-$138M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$393M

Total Liabilities

$165M

Stockholders' Equity

$228M

Cash & Equivalents

$370M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$10M	+29.6%
Gross Profit	$12M	-$46M	+126.6%
Operating Income	-$203M	-$72M	-183.6%
Net Income	-$204M	-$72M	-182.3%